Articles

Results 1 to 5 of 7
Most popular |Most recent


France’s New Anti-Benefits Regime: Core Framework and Key Takeaways

France - October 22 2020 On October 1, 2020, France’s new Anti-Benefits Regime entered into force. The new framework governs transfers of value to healthcare professionals by…

Gary F. Giampetruzzi, Nicola Bonucci.

Key Takeaways from the Novartis 345 Million Dollar Settlement

USA - July 1 2020 On Thursday, June 25, 2020, the United States Department of Justice (“DOJ”) announced a pair of deferred prosecution agreements with one current and…

Gary F. Giampetruzzi, Jonathan Stevens, Michael Mottweiler.

The Trend Continues: As Outward Bound Investments from Japanese Multinationals Continue to Grow, So Do ABAC Compliance and Other Enforcement Risks

OECD, USA - June 24 2020 In 2016, we advised Japanese multinationals that their growing significance in the global economy, primarily as a key source of outward bound…

Gary F. Giampetruzzi, Kyrsten Ponturo, Rakan Ghubej.

Not a U.S.-Fits-All-Proposition: Four Key Considerations When Building the Compliance Framework to Go Global with Patient Support—Part I of II

USA - April 11 2019 Within the U.S., patient support programs (“PSPs”) have drawn increased regulator scrutiny, consistent with their growing importance in the healthcare…

Aisling Murray, Gary F. Giampetruzzi, S. Joy Dowdle.

Another Life Sciences Company Announces a Multi-Million Dollar Settlement in the U.S. Department of Justice’s Relentless Pursuit of Donations to Copay Assistance Charities

USA - June 19 2018 On June 6, 2018, H. Lundbeck A/S announced that its subsidiary, Lundbeck LLC (“Lundbeck”), has reached a $52.6M agreement-in-principle with the U.S…

Gary F. Giampetruzzi, Jane H. Yoon.